Sarcoma Unit, Royal Marsden Hospital, Fulham, London, U.K.
Medical School University of Cyprus and BoC Oncology Center, Nicosia, Cyprus.
Anticancer Res. 2019 Sep;39(9):4891-4896. doi: 10.21873/anticanres.13675.
BACKGROUND/AIM: Epithelioid haemangioendothelioma (EHE) is a rare tumor with a wide spectrum of clinical behavior. There is no consensus on the role of local therapy in symptomatic, multi-focal disease.
A retrospective review of patients presenting to the Royal Marsden Hospital between January 2000 and December 2017 was conducted.
Fifty-three patients with EHE were identified, of which 18 patients (34.0%) received local therapy, and 11 patients (20.8%) underwent active surveillance. A variety of local treatment modalities were used with few toxicities, and local recurrence was managed with other local treatments or systemic therapy. Distal disease progression was infrequent (n=4, 7.5%). Patients who developed pleural effusion (n=5, 9.4%) had poor outcome irrespective of treatment.
Local therapy has a role in a selected patient group managed in a multidisciplinary setting, including patients with indolent disease, and patients with a solitary area of progression/symptomatic disease.
背景/目的:上皮样血管内皮细胞瘤(EHE)是一种罕见的肿瘤,具有广泛的临床行为谱。对于多灶性症状性疾病,局部治疗的作用尚无共识。
对 2000 年 1 月至 2017 年 12 月在皇家马斯登医院就诊的患者进行了回顾性分析。
共发现 53 例 EHE 患者,其中 18 例(34.0%)接受了局部治疗,11 例(20.8%)进行了主动监测。使用了多种局部治疗方法,毒性较小,局部复发采用其他局部治疗或全身治疗进行管理。远处疾病进展少见(n=4,7.5%)。发生胸腔积液的患者(n=5,9.4%)无论治疗与否预后均较差。
在多学科治疗环境中,局部治疗对选定的患者群体有效,包括惰性疾病患者和有孤立进展/症状性疾病区域的患者。